To avoid testing rare or poor-quality ARBS, we targeted those clinical AR peaks identified from a large ChIPseq study [2] that were found in either all normal prostate tissue (n = 7), primary PCa tumors (n = 13), or both. Here, AR is linked to posterior cortical atrophy.